Reuters logo
BRIEF-Shenzhen Neptunus Bioengineering to buy 35 pct stake in Henan pharma firm
April 25, 2017 / 2:50 AM / 7 months ago

BRIEF-Shenzhen Neptunus Bioengineering to buy 35 pct stake in Henan pharma firm

April 25 (Reuters) - Shenzhen Neptunus Bioengineering Co Ltd :

* Says it plans to buy 35 percent stake in a Henan-based pharma firm (target firm) from an enterprise management consulting partnership

* Says co’s wholly owned pharma unit is holding the other 65 percent stake in the target firm currently

Source text in Chinese: goo.gl/n6W4cQ

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below